0000899243-23-005490.txt : 20230217 0000899243-23-005490.hdr.sgml : 20230217 20230217165631 ACCESSION NUMBER: 0000899243-23-005490 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230216 FILED AS OF DATE: 20230217 DATE AS OF CHANGE: 20230217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Snodgres Jon CENTRAL INDEX KEY: 0001613498 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14656 FILM NUMBER: 23643571 MAIL ADDRESS: STREET 1: REPLIGEN CORPORATION, 41 SEYON STREET STREET 2: BUILDING #1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02435 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REPLIGEN CORP CENTRAL INDEX KEY: 0000730272 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042729386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7814499560 MAIL ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-16 0 0000730272 REPLIGEN CORP RGEN 0001613498 Snodgres Jon C/O REPLIGEN CORPORATION 41 SEYON ST., BLDG 1, STE 100 WALTHAM MA 02453 0 1 0 0 Chief Financial Officer Common Stock 2023-02-16 4 S 0 5647 200.00 D 29325 D Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on September 06, 2022. /s/ Kimberly Brown (Attorney in Fact) 2023-02-17